[an error occurred while processing this directive] ����Ƥ���Բ�ѧ��־ 2007, 33(5) 293-295 DOI:     ISSN: 2096-5540 CN: 32-1880/R

����Ŀ¼ | ����Ŀ¼ | ������� | �߼�����                                                            [��ӡ��ҳ]   [�ر�]
����
��չ����
������Ϣ
Supporting info
PDFȫ��
[HTMLȫ��]
�����
�����뷴��
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
����
Email Alert
���·���
���������Ϣ
���Ĺؼ����������
�׹�������
ϸ������
�ź�ת��
���������������
��ʢ��
�ĺ�Ȫ
�Ź�Ӣ
PubMed
Article by YANG Sheng-bo
Article by WEN Hai-quan
Article by ZHANG Gui-ying

�׹�����������ϸ����������ź�ת���ĵ���

��ʢ��, �ĺ�Ȫ, �Ź�Ӣ

���ϴ�ѧ���Ŷ�ҽԺƤ���� ��ɳ 410011

ժҪ��

�׹�����������ҩ��ֲ���׹�����Ҫҩ����ԵĴ����Ե���֮һ,���п����ߡ����ס���������ҩ�����á�����Ҫ���û����ǻ�����춬ø������˿��ԭ����׼�ø�ź�ͨ·�����ƺ�����-��B��ʽ�������á��p53ͬʱ����p21�յ����������͵�,�Ӷ��յ�ϸ���������׹������������ź�ת���ĵ�����ϸ�����಻ͬ�����ڲ��졣

�ؼ����� �׹�������   ϸ������   �ź�ת��  

Effects of triptolide on cell apoptosis-related signal transduction

Department of Dermatology, Second Xiangya Hospital, Central South University, Changsha 410011, China

Department of Dermatology, Second Xiangya Hospital, Central South University, Changsha 410011, China

Abstract:

Triptolide, a diterpene triepoxide, is the principal active component of Tripterygium wilfordii Hook. F. abstracts. It has been shown to possess anti-inflammatory, immunosuppressive and anti-neoplastic properties, which are mainly related to the induction of apoptosis via the activation of caspase enzymes, mitogen-activated protein kinase signaling pathway and p53, as well as the inhibition of trans-activation by nuclear factor-��B and growth arrest induced by p21, and so on. The effects of triptolide on the signal transduction vary with the types of cells.

Keywords: Triptolide   Apoptosis   Signal transduction  
�ո����� 2006-12-05 �޻�����  ����淢������  
DOI:
������Ŀ:

ͨѶ����:
���߼��:

�ο����ף�
[1] Liu Q,Chen T,Chen H,et al.Triptolide (PG-490) induces apoptosis of dendritic cells through sequential p38 MAP kinase phosphorylation and caspase 3 activation.Biochem Biophys Res Commun,2004,319 (3):980-986.
[2] Choi YJ,Kim TG,Kim YH,et al.Immunosuppressant PG490 (triptolide) induces apoptosis through the activation of caspase-3 and down-regulation of XIAP in U937 cella.Biochem Pharmacol,2003,66 (2):273-280.
[3] Yinjun L,Jie J,Yungui W.Triptolide inhibits transcription factor NF-kappaB and induces apoptosis of multiple myeloma cells.Leuk Res,2005,29 (1):99-105.
[4] Carter BZ,M ak DH,Schober WD,et al.Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells.Blood,2006,108 (2):630637.
[5] Kim YH,Lee SH,Lee JY,et al.Triptolide inhibits murine-inducible nitric oxide synthase expression by down-regulating lipopolysaccharide-induced activity of nuclear factor-kappa B and c-Jun NH2-terminal kinase.Eur J Pharmacol,2004,494(1):1-9.
[6] Chen P,Li J,Barnes J,et al.Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages.J Immunol,2002,169 (11):6408-6416.
[7] Miyata Y,Sato T,Ito A.Triptolide,a diterpenoid triepoxide,induces antitumor proliferation via activation of c-Jun NH2-terminal kinase 1 by decreasing phosphatidylinositol 3-kinase activity in human tumor cells.Biochem Biophys Res Commun,2005,336(4):1081-1086.
[8] Wan CK,Wang C,Cheung HY,et al.Triptolide induces Bcl-2 cleavage and mitochondria dependent apoptosis in p53-deficient HL-60 cells.Cancer Lett,2006,241 (1):31-41.
[9] Frese S,Pirnia F,Miescher D,et al.PG490-mediated sensitization of lung cancer cells to APo2L/TRAIL-induced apoptosis requires activation of ERK2.Oncogene,2003,22 (35):5427-5435.
[10] Du ZY,Li XY,Li YC,et al.Analysis of triptolide-regulated gene expression in Jurkat cells by complementary DNA microarray.Acta Pharmacol Sin,2003,24 (9):864-872.
[11] Wang CY,Cusack JC Jr,Liu R,et al.Control of inducible chemoresistance:enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB.Nat Med,1999,5(4):412-417.
[12] Liu H,Liu ZH,Chen ZH,et al.Triptolide:a potent inhibitor of NF-kappa B in T-lymphocytes.Acta Pharmacol Sin,2000,21(9):782-786.
[13] Lee KY,Park JS,Jee YK,et al.Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-kappaB activation.Exp Mol Med,2002,34 (6):462-468.
[14] Qiu D,Zhao G,Aoki Y,et al.Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation.J Biol Chem,1999,274 (19):13443-13450.
[15] Chang WT,Kang JJ,Lee KY,et al.Triptolide and chemotherapy cooperate in tumor cell apoptosis.A role for the p53 pathway.J Biol Chem,2001,276(3):2221-2227.
[16] Jiang XH,Wong BC,Lin MC,et al.Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.Oncogene,2001,20(55):8009-8018.
[17] Kiviharju TM,Lecane PS,Sellers RG,et al.Antiproliferative and proapoptotic activities of triptolide (PG490),a natural product entering clinical trials,on primary cultures of human prostatic epithelial cells.Clin Cancer Res,2002,8 (8):2666-2674.
[18] Yang S,Chen J,Guo Z,et al.Triptolide inhibits the growth and metastasis of solid tumors.Mol Cancer Ther,2003,2 (1):65-72.
[19] Fidler JM,Li K,Chung C,et al.PG490-88,a derivative of triptolide,causes tumor regression and sensitizes tumors to chemotherapy.Mol Cancer Ther,2003,2 (9):855-862.
�������������

�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���޹ص�����!�������ݲ�����վ�۵�.)

Copyright 2008 by ����Ƥ���Բ�ѧ��־